Showing results (541-550 of 921) with videos related to
Sort By:
Pageof 93
Nanoscale|August 24, 2017
Strain and electric-field control of magnetism in supercrystalline iron oxide nanoparticle-BaTiO3 compositesL-M Wang, O Petracic, E Kentzinger, et al.Toxicology in Vitro : an International Journal Published in Association with BIBRA|September 8, 2012
A label-free, impedance-based real time assay to identify drug-induced toxicities and differentiate cytostatic from cytotoxic effectsS Kustermann, F Boess, A Buness, et al.Arteriosclerosis (Dallas, Tex.)|July 1, 1989
Effect of dietary omega-3 fatty acid on serum lipids, platelet function, and atherosclerosis in Watanabe heritable hyperlipidemic rabbitsF J Clubb, J M Schmitz, M M Butler, et al.Addictive Behaviors|December 19, 2021
Nonjudgmental acceptance: Associations with substance-related cue reactivity in adults with substance use disorders and posttraumatic stressAnka A Vujanovic, Heather E Webber, Margaret C Wardle, et al.Cancer Research|September 15, 2000
Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptidesM Schmitz, P Diestelkoetter, B Weigle, et al.The American Journal on Addictions|October 31, 2009
High-dose naltrexone therapy for cocaine-alcohol dependenceJoy M Schmitz, Jan A Lindsay, Charles E Green, et al.The American Journal of Drug and Alcohol Abuse|February 21, 2002
Determining predictors of attrition in an outpatient substance abuse programShelly L Sayre, Joy M Schmitz, Angela L Stotts, et al.British Journal of Cancer|March 5, 2004
Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein prosteinA Kiessling, S Stevanovic, S Füssel, et al.Breast Cancer Research and Treatment|December 18, 2007
The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07)Susanne Taucher, Guenther G Steger, Raimund Jakesz, et al.Cancer Research|October 16, 1999
Modified vaccinia virus Ankara for delivery of human tyrosinase as melanoma-associated antigen: induction of tyrosinase- and melanoma-specific human leukocyte antigen A*0201-restricted cytotoxic T cells in vitro and in vivoI Drexler, E Antunes, M Schmitz, et al.Pageof 93